Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Multi-modal normalization of resting-state using local physiology reduces changes in functional connectivity patterns observed in mTBI patients.

Champagne AA, Coverdale NS, Ross A, Chen Y, Murray CI, Dubowitz D, Cook DJ.

Neuroimage Clin. 2020 Feb 4;26:102204. doi: 10.1016/j.nicl.2020.102204. [Epub ahead of print]

2.

I Ks ion-channel pore conductance can result from individual voltage sensor movements.

Westhoff M, Eldstrom J, Murray CI, Thompson E, Fedida D.

Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7879-7888. doi: 10.1073/pnas.1811623116. Epub 2019 Mar 27.

3.

Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way.

Fert-Bober J, Murray CI, Parker SJ, Van Eyk JE.

Circ Res. 2018 Apr 27;122(9):1221-1237. doi: 10.1161/CIRCRESAHA.118.310966. Review.

4.

A Proteomics Workflow for Dual Labeling Biotin Switch Assay to Detect and Quantify Protein S-Nitroylation.

Chung HS, Murray CI, Van Eyk JE.

Methods Mol Biol. 2018;1747:89-101. doi: 10.1007/978-1-4939-7695-9_8.

PMID:
29600453
5.

Photo-Cross-Linking of IKs Demonstrates State-Dependent Interactions between KCNE1 and KCNQ1.

Westhoff M, Murray CI, Eldstrom J, Fedida D.

Biophys J. 2017 Jul 25;113(2):415-425. doi: 10.1016/j.bpj.2017.06.005.

6.

Unnatural amino acid photo-crosslinking of the IKs channel complex demonstrates a KCNE1:KCNQ1 stoichiometry of up to 4:4.

Murray CI, Westhoff M, Eldstrom J, Thompson E, Emes R, Fedida D.

Elife. 2016 Jan 23;5. pii: e11815. doi: 10.7554/eLife.11815.

7.

Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection.

Chung HS, Murray CI, Venkatraman V, Crowgey EL, Rainer PP, Cole RN, Bomgarden RD, Rogers JC, Balkan W, Hare JM, Kass DA, Van Eyk JE.

Circ Res. 2015 Oct 23;117(10):846-57. doi: 10.1161/CIRCRESAHA.115.307336. Epub 2015 Sep 3.

8.

Quantification of mitochondrial S-nitrosylation by CysTMT⁶ switch assay.

Murray CI, Chung HS, Uhrigshardt H, Van Eyk JE.

Methods Mol Biol. 2013;1005:169-79. doi: 10.1007/978-1-62703-386-2_14.

PMID:
23606257
9.

Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system.

Chung HS, Wang SB, Venkatraman V, Murray CI, Van Eyk JE.

Circ Res. 2013 Jan 18;112(2):382-92. doi: 10.1161/CIRCRESAHA.112.268680. Review.

10.

Redox regulation of mitochondrial ATP synthase.

Wang SB, Murray CI, Chung HS, Van Eyk JE.

Trends Cardiovasc Med. 2013 Jan;23(1):14-8. doi: 10.1016/j.tcm.2012.08.005. Review.

11.

A twist on quantification: measuring the site occupancy of S-nitrosylation.

Murray CI, Van Eyk JE.

Circ Res. 2012 Oct 26;111(10):1253-5. doi: 10.1161/CIRCRESAHA.112.278721. No abstract available.

12.

Chasing cysteine oxidative modifications: proteomic tools for characterizing cysteine redox status.

Murray CI, Van Eyk JE.

Circ Cardiovasc Genet. 2012 Oct 1;5(5):591. doi: 10.1161/CIRCGENETICS.111.961425. No abstract available.

13.

Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function.

Gao WD, Murray CI, Tian Y, Zhong X, DuMond JF, Shen X, Stanley BA, Foster DB, Wink DA, King SB, Van Eyk JE, Paolocci N.

Circ Res. 2012 Sep 28;111(8):1002-11. Epub 2012 Jul 31.

14.

Identification of novel interaction between annexin A2 and keratin 17: evidence for reciprocal regulation.

Chung BM, Murray CI, Van Eyk JE, Coulombe PA.

J Biol Chem. 2012 Mar 2;287(10):7573-81. doi: 10.1074/jbc.M111.301549. Epub 2012 Jan 10.

15.

Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay.

Murray CI, Uhrigshardt H, O'Meally RN, Cole RN, Van Eyk JE.

Mol Cell Proteomics. 2012 Feb;11(2):M111.013441. doi: 10.1074/mcp.M111.013441. Epub 2011 Nov 29.

16.

Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.

Gebska MA, Stevenson BK, Hemnes AR, Bivalacqua TJ, Haile A, Hesketh GG, Murray CI, Zaiman AL, Halushka MK, Krongkaew N, Strong TD, Cooke CA, El-Haddad H, Tuder RM, Berkowitz DE, Champion HC.

Cardiovasc Res. 2011 May 1;90(2):353-63. doi: 10.1093/cvr/cvq410. Epub 2011 Mar 18.

17.

Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Tocchetti CG, Stanley BA, Murray CI, Sivakumaran V, Donzelli S, Mancardi D, Pagliaro P, Gao WD, van Eyk J, Kass DA, Wink DA, Paolocci N.

Antioxid Redox Signal. 2011 May 1;14(9):1687-98. doi: 10.1089/ars.2010.3859. Epub 2011 Mar 3. Review.

18.

Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection.

Murray CI, Kane LA, Uhrigshardt H, Wang SB, Van Eyk JE.

Mol Cell Proteomics. 2011 Mar;10(3):M110.004721. doi: 10.1074/mcp.M110.004721. Epub 2010 Oct 29.

19.

Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow.

Gundry RL, White MY, Murray CI, Kane LA, Fu Q, Stanley BA, Van Eyk JE.

Curr Protoc Mol Biol. 2009 Oct;Chapter 10:Unit10.25. doi: 10.1002/0471142727.mb1025s88. Review.

20.
21.

Judicial gatekeeping and the social construction of the admissibility of expert testimony.

Merlino ML, Murray CI, Richardson JT.

Behav Sci Law. 2008;26(2):187-206. doi: 10.1002/bsl.806.

PMID:
18344168

Supplemental Content

Loading ...
Support Center